Overview

This trial is active, not recruiting.

Condition peripheral artery disease (pad).
Treatment offer and report protocol
Sponsor Dartmouth-Hitchcock Medical Center
Collaborator Society for Vascular Surgery
Start date August 2014
End date March 2016
Trial size 156 participants
Trial identifier NCT02220686, D14197

Summary

The purpose of the study is to see if vascular physicians (your provider) using a combination of proven smoking cessation tools in an organized way can help vascular patients quit smoking better than usual.

The doctors where you are being treated have been chosen to either provide:

the combination therapy of giving you advice, considering prescribing medications to help you quit smoking, and referring you to a phone quitline, or to continue their usual smoking cessation practices (which may include all, some, or none of the treatments above).

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose treatment
Arm
(Experimental)
Physician advice to stop smoking, referral to state Quitline, and physician considers prescribing nicotine replacement therapy.
offer and report protocol
Physician advice to stop smoking, referral to state Quitline, and physician considers prescribing nicotine replacement therapy.
(No Intervention)
Physician will follow their institution's standard of care for smoking cessation.

Primary Outcomes

Measure
Efficacy of the "Offer and Report" protocol for change in smoking status from Baseline Visit to 3 Month Visit
time frame: Change in smoking status from Baseline Visit to 3 Month Visit

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Age >18 - Current smoker - Plan to have a Vascular Quality Initiative (VQI) procedure in > 7 days Exclusion Criteria: - Pregnant Women, Fetuses and Neonates - Children - People with impaired decision-making capacity

Additional Information

Official title Vascular Physician Offer and Report (VAPOR) Trial
Principal investigator Philip Goodney, MD, MS
Trial information was received from ClinicalTrials.gov and was last updated in January 2016.
Information provided to ClinicalTrials.gov by Dartmouth-Hitchcock Medical Center.